| Japanese |
|---|
| Title | クローン病におけるガリウムシンチグラフィの意義 |
|---|
| Subtitle | 原著 |
|---|
| Authors | 斉藤泰博*, 綾部時芳**, 油野民雄*, 秀毛範至*, 高塩哲也*, 山田有則*, 吉川大平*, 川口香織*, 遠山節子*, 吉田弘*, 佐藤順一***, 石川幸雄*** |
|---|
| Authors(kana) | |
|---|
| Organization | *旭川医科大学放射線科, **第三内科, ***放射線部 |
|---|
| Journal | 核医学 |
|---|
| Volume | 32 |
|---|
| Number | 4 |
|---|
| Page | 387-394 |
|---|
| Year/Month | 1995/4 |
|---|
| Article | 原著 |
|---|
| Publisher | 日本核医学会 |
|---|
| Abstract | 「要旨」クローン病における67Gaシンチグラフィの有用性と, 治療法選択に際してのその役割について検討した. 対象はクローン病と診断された30患者であり, 67Ga-citrate 111 MBq静注後, 48時間と72時間にplanar像およびSPECT像を撮像した. 全体の陽性率は42.1%であった. 陽性例においては, 78.6%がなんらかの外科的処置を必要とした. これに対して, 陰性例では, 外科的処置の施行率は18.8%と有意に低率であった. 一方, 手術施行例から見ると, 75.0%の症例が術前に陽性所見を示していた. したがって, 67Gaシンチグラフィ陽性例は, 内科的な治療に抵抗する手術のハイリスク群であると考えられた. |
|---|
| Practice | 臨床医学：一般 |
|---|
| Keywords | Gallium scintigraphy, Crohn's disease, SPECT |
|---|
| English |
|---|
| Title | The Role of Gallium-67 Citrate Scintigraphy in Crohn's Disease |
|---|
| Subtitle | Original Articles |
|---|
| Authors | Yasuhiro SAITO*, Tokiyoshi AYABE**, Tamio ABURANO*, Noriyuki SHUKE*, Tetsuya TAKASHIO*, Tomonori YAMADA*, Daihei YOSHIKAWA*, Kaori KAWAGUCHI*, Setsuko TOUYAMA*, Hiroshi YOSHIDA*, Junichi SATO***, Yukio ISHIKAWA*** |
|---|
| Authors(kana) | |
|---|
| Organization | *Department of Radiology, **Third Department of Internal Medicine, ***Department of Clinical Radiology, Asahikawa Medical College |
|---|
| Journal | The Japanese Journal of nuclear medicine |
|---|
| Volume | 32 |
|---|
| Number | 4 |
|---|
| Page | 387-394 |
|---|
| Year/Month | 1995/4 |
|---|
| Article | Original article |
|---|
| Publisher | THE JAPANESE SOCIETY OF NUCLEAR MEDICINE |
|---|
| Abstract | [Summary] We investigated the usefulness of gallium scintigraphy and its importance in the choice of a treatment method for Crohn's disease. The subjects for the study were 30 patients diagnosed as Crohn's disease. After intravenous injections of 67Ga-citrate 111 MBq, planar and SPECT images were taken at 48 and 72 hrs. The overall positive rate was 42.1%, and among the positive cases, 78.6% required surgical treatment. On the other hand, surgical treatment was only performed in 18.8% of the negative cases, which was significantly low percentage. However, since 75% of the cases, in whom surgical treatment was performed, showed preoperative positive 67Ga results, positive cases detected by 67Ga scintigraphy were considered to be high-risk cases requiring surgical treatment. |
|---|
| Practice | Clinical medicine |
|---|
| Keywords | Gallium scintigraphy, Crohn's disease, SPECT |
|---|